These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 10940356

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro inhibitory effects of J-113397 on nociceptin/orphanin FQ-stimulated.
    Ichikawa D, Ozaki S, Azuma T, Nambu H, Kawamoto H, Iwasawa Y, Takeshima H, Ohta H.
    Neuroreport; 2001 Jun 13; 12(8):1757-61. PubMed ID: 11409754
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: in vitro studies.
    Spagnolo B, Carrà G, Fantin M, Fischetti C, Hebbes C, McDonald J, Barnes TA, Rizzi A, Trapella C, Fanton G, Morari M, Lambert DG, Regoli D, Calò G.
    J Pharmacol Exp Ther; 2007 Jun 13; 321(3):961-7. PubMed ID: 17329552
    [Abstract] [Full Text] [Related]

  • 5. Identification of the G-protein-coupled ORL1 receptor in the mouse spinal cord by [35S]-GTPgammaS binding and immunohistochemistry.
    Narita M, Mizoguchi H, Oji DE, Dun NJ, Hwang BH, Nagase H, Tseng LF.
    Br J Pharmacol; 1999 Nov 13; 128(6):1300-6. PubMed ID: 10578145
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cloning and characterization of the rhesus monkey nociceptin/orphanin FQ receptor.
    Koga K, Ichikawa D, Nambu H, Azuma-Kanoh T, Sakai N, Takaki-Kawagoe H, Ozaki S, Ohta H.
    Genes Genet Syst; 2009 Oct 13; 84(5):319-25. PubMed ID: 20154418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.
    Huang P, Kehner GB, Cowan A, Liu-Chen LY.
    J Pharmacol Exp Ther; 2001 May 13; 297(2):688-95. PubMed ID: 11303059
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of [(pF)Phe(4)]nociceptin/orphanin FQ-(1-13)NH(2) on GTPgamma(35)S binding and cAMP formation in Chinese hamster ovary cells expressing the human nociceptin/orphanin FQ receptor.
    McDonald J, Barnes TA, Calo G, Guerrini R, Rowbotham DJ, Lambert DG.
    Eur J Pharmacol; 2002 May 17; 443(1-3):7-12. PubMed ID: 12044785
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro and ex vivo effects of a selective nociceptin/orphanin FQ (N/OFQ) peptide receptor antagonist, CompB, on specific binding of [3H]N/OFQ and [35S]GTPgammaS in rat brain and spinal cord.
    Yamada S, Kusaka T, Urayama A, Kimura R, Watanabe Y.
    Br J Pharmacol; 2003 Aug 17; 139(8):1462-8. PubMed ID: 12922933
    [Abstract] [Full Text] [Related]

  • 15. Binding and GTPgammaS autoradiographic analysis of preproorphanin precursor peptide products at the ORL1 and opioid receptors.
    Neal CR, Owens CE, Taylor LP, Hoversten MT, Akil H, Watson SJ.
    J Chem Neuroanat; 2003 Jul 17; 25(4):233-47. PubMed ID: 12842269
    [Abstract] [Full Text] [Related]

  • 16. N-terminal modifications leading to peptide ORL1 partial agonists and antagonists.
    Judd AK, Kaushanskaya A, Tuttle DJ, Sanchez A, Khroyan T, Polgar W, Toll L.
    J Pept Res; 2003 Nov 17; 62(5):191-8. PubMed ID: 14531842
    [Abstract] [Full Text] [Related]

  • 17. Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5'-O-(gamma-thio)-triphosphate binding in rat brain membranes.
    Albrecht E, Samovilova NN, Oswald S, Baeger I, Berger H.
    J Pharmacol Exp Ther; 1998 Aug 17; 286(2):896-902. PubMed ID: 9694948
    [Abstract] [Full Text] [Related]

  • 18. (2S,3R) beta-methyl-2',6'-dimethyltyrosine-L-tetrahydroisoquinoline-3-carboxylic acid [(2S,3R)TMT-L-Tic-OH] is a potent, selective delta-opioid receptor antagonist in mouse brain.
    Hosohata K, Varga EV, Alfaro-Lopez J, Tang X, Vanderah TW, Porreca F, Hruby VJ, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 2003 Feb 17; 304(2):683-8. PubMed ID: 12538822
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb.
    Onali P, Olianas MC.
    Br J Pharmacol; 2004 Nov 17; 143(5):638-48. PubMed ID: 15451772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.